Home
Calculator
Restore
Contact
Restore Prior Entries
AML Composite Model Calculator
Instructions
Each section has additional instructions which you can display by clicking on the section's
icon.
Please check a box or enter a value as it applies to the patient's condition- keeping in mind that in order the for the model to be accurate, all necessary components need to be entered.
Click on one of the buttons at the bottom of the page to calculate the score or save your entries for later.
You need to correct the following errors before a score can be calculated:
A) Augmented HCT-CI
1. Arrhythmia (score = 1)
a.
Atrial fibrillation
Yes
b.
Atrial flutter
Yes
c.
Supraventricular tachycardia
Yes
d.
Sick sinus syndrome
Yes
e.
Heart block
Yes
f.
Ventricular arrhythmia
Yes
g.
Other, specify:
Yes
2. Cardiovascular Score (score = 1)
a.
Coronary artery disease
Yes
b.
Congestive heart failure
Yes
c.
Ejection fraction
%
d.
Shortening fraction (for pediatrics)
%
3. Inflammatory Bowel Disease (score = 1)
a.
Crohn's disease
Yes
b.
Ulcerative colitis
Yes
4. Diabetes (score = 1)
a.
Diabetes
Yes
b.
Steroid-induced hyperglycemia
Yes
5. Cerebro-Vascular Disease (score = 1)
a.
Transient ischemic attack
Yes
b.
Subarachnoid hemorrhage
Yes
c.
Cerebral thrombosis
Yes
d.
Cerebral embolism
Yes
e.
Cerebral hemorrhage
Yes
6. Psychiatric Disturbance (score = 1)
a.
Depression
Yes
b.
Anxiety
Yes
c.
Other, specify:
Yes
7. Hepatic Comorbidity (score = 1 or 3)
a.
Total bilirubin:
upper limit of normal value:
Bilirubin patient value:
b.
Aspartate transaminase (AST):
upper limit of normal value:
AST patient value:
c.
Alanine transaminase (ALT):
upper limit of normal value:
ALT patient value:
d.
Alkaline Phosphatase (ALK):
upper limit of normal value:
ALK patient value:
e.
Hepatitis B
Yes
f.
Hepatitis C
Yes
g.
Liver cirrhosis or fibrosis
Yes
8. Obesity (score = 1)
a.
Patient height (cm):
Patient weight (kg):
Calculated BMI:
b.
BMI-for-age percentile, for patients <= 18 yr old:
%
9. Infection (score = 1)
a.
Documented infection
Yes
b.
Fever of unknown origin
Yes
c.
Pumonary nodules suspicious of fungal pneumonia
Yes
d.
PPD positive requiring TB prophlaxis
Yes
e.
Other, specify:
Yes
10. Rheumatologic Score (score = 2)
a.
Systemic lupus erythematosus
Yes
b.
Rheumatoid arthritis
Yes
c.
Polymyositis
Yes
d.
Mixed connective tissue disease
Yes
e.
Polymyalgia rheumatica
Yes
f.
Other, specify:
Yes
11. Peptic Ulcer (score = 2)
a.
Gastric ulcer
Yes
b.
Duodenal ulcer
Yes
12. Renal Comorbidity (score = 2)
a.
Creatinine clearance patient value:
ml/min
b.
Serum Creatinine
Please select units and enter value
i.
Creatinine units:
mg/dL
umol/L
ii.
Serum creatinine patient value:
c.
Patient on dialysis
Yes
d.
Prior renal transplantation
Yes
13. Pulmonary Score (score = 2 or 3)
a.
Diffusion capacity of carbon monoxide (DLco)
Please enter items i and ii
i.
Percentage of measured uncorrected DLco divided by predicted DLco:
%
ii.
Concurrent hemoglobin value:
g/dl
iii.
Calculated pct of corrected DLco (Dinakara equation):
b.
Forced expiratory volume in 1 second (FEV1)
Please enter enter a value
i.
Percentage of measured forced expiratory volume in 1 second (FEV1) divided by predicted FEV1:
%
c.
Shortness of breath on slight activity
Yes
d.
Shortness of breath at rest
Yes
e.
Oxygen supplementation
Yes
14. Prior Solid Tumor (score = 3)
a.
Prior solid tumor,
type:
Yes
15. Heart Valve Disease (score = 3)
a.
Valve stenosis,
type of valve:
Yes
b.
Valve insufficiency,
type of valve:
Yes
c.
Prosthetic valve,
type of valve:
Yes
d.
Symptomatic mitral valve prolapse:
Yes
16. Hypoalbuminemia (score = 1)
a.
Albumin patient value
17. Elevated LDH (score = 1 or 2)
a.
LDH patient value
U/L
B) Patient Age
Patient Age
C) Cytogenetic-molecular risks per ELN 2017 Classification
A.
Favorable risk (score = 0)
I.
t(8;21)
Yes
II.
inv(16)
Yes
III.
t(16;16)
Yes
IV.
Mutated NPM1 (counted if either of the two situations below are true)
i.
FLT3-ITD
No or
ii.
FLT3-ITD present but low (allelic ratio is <0.5)
Yes
V.
Biallelic mutated CEBPA
Yes
B.
Intermediate risk (score = 1)
I.
Mutated NPM1 (counted if either of the two situations below are true)
i.
FLT3-ITD present (high: meaning allelic ratio is >0.5)
Yes or
ii.
FLT3-ITD present (unknown allelic)
Yes
II.
Wild type NPM1 (counted if either of the two situations below are true)
i.
FLT3-ITD
No
ii.
FLT3-ITD present but low (allelic ratio is <0.5)
Yes
III.
t(9;11)
Yes
IV.
Cytogenetic abnormalities not classified as favorable or adverse
Yes
C.
Adverse risk (score = 3)
I.
t(6;9)
Yes
II.
t(v;11q23.3)
Yes
III.
t(9.22)
Yes
IV.
inv(3) or t(3;3)(q21.3;q26.2);GATA2,MECOM(EVI1)
Yes
V.
-5 or del(5q);-7;-17
Yes
VI.
monosomal karyotype
Yes
VII.
complex karyotype
Yes
VIII.
Wild type NPM1 and FLT3-ITD (Meaning allelic ratio is >0.5)
Yes
IX.
mutated RUNX1
Yes
X.
mutated ASXL1
Yes
XI.
mutated TP53
Yes